Get the Stockscreener App
9.50
0.31%
-0.03
After Hours:
9.40
-0.10
-1.05%
89 Bio Inc stock is traded at $9.50, with a volume of 1.08M.
It is down -0.31% in the last 24 hours and down -3.26% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$9.53
Open:
$9.4
24h Volume:
1.08M
Relative Volume:
0.58
Market Cap:
$1.39B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-4.8223
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
-4.81%
1M Performance:
-3.26%
6M Performance:
-1.04%
1Y Performance:
+3.71%
1-Day Range:
$9.31
$9.76
1-Week Range:
$9.12
$9.9565
52-Week Range:
$4.16
$11.84
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETNB
89 Bio Inc
|
9.50 | 1.39B | 0 | -174.61M | -165.54M | -1.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-14-25 | Initiated | Goldman | Neutral |
| Mar-13-25 | Initiated | Citigroup | Buy |
| Feb-04-25 | Initiated | Wolfe Research | Outperform |
| Apr-22-24 | Resumed | BofA Securities | Buy |
| Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-23 | Initiated | UBS | Buy |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Resumed | BTIG Research | Buy |
| May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-20 | Initiated | Raymond James | Strong Buy |
| Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-20 | Initiated | Piper Sandler | Overweight |
| Jul-23-20 | Initiated | BTIG Research | Buy |
| Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
| Dec-09-19 | Initiated | BofA/Merrill | Neutral |
| Dec-09-19 | Initiated | Oppenheimer | Outperform |
| Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
| Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
What Fibonacci levels say about 89bio Inc. reboundFree Wealth Building Stock Market Ideas - Newser
What institutions are buying 89bio Inc. stock nowTechnical Chart Summary for Momentum Stocks - Newser
How 89bio Inc. stock performs during market volatilityFree Weekly Setup With 3x Return Potential - Newser
What makes 89bio Inc. stock price move sharplyFree Entry Plan for Oversold Reversal Stocks - Newser
Can 89bio Inc. stock recover from recent declineWeekly Signal Report with Trend Summary - Newser
Quantitative breakdown of 89bio Inc. recent movePredictive AI Signals for Short-Term Trading - Newser
Evaluating 89bio Inc. with trendline analysisSwing Watchlist With Tight Stop Placement - Newser
89bio Inc. recovery potential after sell offBollinger Band Squeeze and Expansion Analysis - Newser
How moving averages guide 89bio Inc. tradingPrice Action Based Buy Zone Forecast - Newser
What is 89bio Inc. company’s growth strategyDiscover undervalued stocks before they soar - jammulinksnews.com
When is 89bio Inc. stock expected to show significant growthStrong return on assets - jammulinksnews.com
What institutional investors are buying 89bio Inc. stockRemarkable growth - jammulinksnews.com
What markets is 89bio Inc. expanding into Is MNSB stock a good long term investment optionCapitalize on fast-growing stocks today - jammulinksnews.com
Why 89bio Inc. stock attracts strong analyst attentionVolume Spike Detection for Early Breakouts - Newser
What Fibonacci levels say about 89bio Inc. rebound Short-Term Trade Setup with Forecast Insight - Newser
What is the risk reward ratio of investing in 89bio Inc. stockInvest confidently with professional market insights - jammulinksnews.com
Published on: 2025-07-28 01:29:07 - jammulinksnews.com
How many analysts rate 89bio Inc. as a “Buy”Build wealth with proven stock investing tactics - jammulinksnews.com
New York State Common Retirement Fund Purchases 9,600 Shares of 89BIO (NASDAQ:ETNB) - Defense World
What analysts say about 89bio Inc. stockConsistent high-performance stocks - PrintWeekIndia
Will 89bio Inc. stock benefit from AI tech trendsFree Market Dynamics Reports - jammulinksnews.com
What analysts say about 89bio Inc. stock outlookMarket-crushing profits - jammulinksnews.com
What drives 89bio Inc. stock priceHigh-profit capital plays - PrintWeekIndia
89bio Inc. Stock Analysis and ForecastUnmatched market performance - jammulinksnews.com
89BIO (NASDAQ:ETNB) Shares Acquired by Arizona State Retirement System - Defense World
89BIO (NASDAQ:ETNB) Receives $26.43 Consensus Price Target from Brokerages - Defense World
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):